ask="N/A"
ask_size="N/A"
average_daily_volume="187793"
bid="17.65"
bid_size="2100"
book_value="6.18"
change="-0.40"
change_from_200_day_moving_average="0.41"
change_from_50_day_moving_average="-1.93"
change_from_52_week_high="-6.00"
change_From_52_week_low="5.95"
change_in_percent="-2.14%"
close="18.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.18"
ebitda="-77.71M"
eps_estimate_current_year="-3.60"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-3.31"
ex_dividend_date="N/A"
float_shares="19254000"
high="18.55"
high_52_weeks="24.30"
last_trade_date="3/14/2017"
last_trade_price="18.30"
last_trade_size="3088"
last_trade_time="4:00pm"
low="18.00"
low_52_weeks="12.35"
market_capitalization="536.54M"
moving_average_200_day="17.89"
moving_average_50_day="20.23"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="39.67"
open="18.55"
pe_ratio="N/A"
peg_ratio="-0.45"
percent_change_from_200_day_moving_average="+2.29%"
percent_change_from_50_day_moving_average="-9.53%"
percent_change_from_52_week_high="-24.69%"
percent_change_from_52_week_low="+48.18%"
previous_close="18.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.03"
price_per_sales="1827.55"
revenue="300000.00"
shares_outstanding="29319000"
short_ratio="32.21"
stock_exchange="NGM"
symbol="RVNC"
volume="112946"
weeks_range_52="12.35 - 24.30"
